|
|
||||||||||
|
|
J Am Coll Cardiol, 2007; 49:675-683, doi:10.1016/j.jacc.2006.07.073
(Published online 25 January 2007). © 2007 by the American College of Cardiology Foundation |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








,4
,3
* Midwest Heart Foundation, Lombard, Illinois
John D. Dingell VA Medical Center, Division of Cardiology, Department of Medicine, Wayne State University, Detroit, Michigan
Division of Cardiology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Division of Cardiology, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota
|| San Francisco Veterans Affairs Medical Center/University of California, San Francisco, California
¶ San Diego Cardiac Center, Sharp Memorial Hospital, San Diego, California
# Division of Cardiology, Department of Medicine, Brigham and Womens Hospital, Harvard University, Boston, Massachusetts
** Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, Maryland

Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio

Division of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois

CHF Solutions, Brooklyn Park, Minnesota
Manuscript received April 10, 2006; revised manuscript received June 9, 2006, accepted July 6, 2006.
* Reprint requests and correspondence: Dr. Maria Rosa Costanzo, Midwest Heart Foundation, Edward Heart Hospital, 4th Floor, 801 South Washington Street, P.O. Box 3226, Naperville, Illinois 60566. (Email: mcostanzo{at}midwestheart.com).
Partially presented as a Late Breaking Clinical Trial at the 55th Scientific Sessions of the American College of Cardiology, March 11–14, 2006, Atlanta, Georgia.
Objectives: This study was designed to compare the safety and efficacy of veno-venous ultrafiltration and standard intravenous diuretic therapy for hypervolemic heart failure (HF) patients.
Background: Early ultrafiltration may be an alternative to intravenous diuretics in patients with decompensated HF and volume overload.
Methods: Patients hospitalized for HF with
2 signs of hypervolemia were randomized to ultrafiltration or intravenous diuretics. Primary end points were weight loss and dyspnea assessment at 48 h after randomization. Secondary end points included net fluid loss at 48 h, functional capacity, HF rehospitalizations, and unscheduled visits in 90 days. Safety end points included changes in renal function, electrolytes, and blood pressure.
Results: Two hundred patients (63 ± 15 years, 69% men, 71% ejection fraction
40%) were randomized to ultrafiltration or intravenous diuretics. At 48 h, weight (5.0 ± 3.1 kg vs. 3.1 ± 3.5 kg; p = 0.001) and net fluid loss (4.6 vs. 3.3 l; p = 0.001) were greater in the ultrafiltration group. Dyspnea scores were similar. At 90 days, the ultrafiltration group had fewer patients rehospitalized for HF (16 of 89 [18%] vs. 28 of 87 [32%]; p = 0.037), HF rehospitalizations (0.22 ± 0.54 vs. 0.46 ± 0.76; p = 0.022), rehospitalization days (1.4 ± 4.2 vs. 3.8 ± 8.5; p = 0.022) per patient, and unscheduled visits (14 of 65 [21%] vs. 29 of 66 [44%]; p = 0.009). No serum creatinine differences occurred between groups. Nine deaths occurred in the ultrafiltration group and 11 in the diuretics group.
Conclusions: In decompensated HF, ultrafiltration safely produces greater weight and fluid loss than intravenous diuretics, reduces 90-day resource utilization for HF, and is an effective alternative therapy. (The UNLOAD trial; http://clinicaltrials.gov/ct/show/NCT00124137?order=1; NCT00124137 [ClinicalTrials.gov] ).
| |||
Related Article
J. Am. Coll. Cardiol. 2007 49: 684-686.
This article has been cited by other articles:
![]() |
S. Wingate and D. L.-M. Wiegand End-of-Life Care in the Critical Care Unit for Patients With Heart Failure Crit. Care Nurse, April 1, 2008; 28(2): 84 - 94. [Full Text] [PDF] |
||||
![]() |
J. R. Teerlink Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in heart failure patients. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1080 - 1082. [Full Text] [PDF] |
||||
![]() |
C. Ronco, J. A. Kellum, R. Bellomo, and A. A. House Potential Interventions in Sepsis-Related Acute Kidney Injury Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 531 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kazory and E. A. Ross Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective Circulation, February 19, 2008; 117(7): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al. Highlights of the year in JACC 2007. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512. [Full Text] [PDF] |
||||
![]() |
W.H. W. Tang and G. S. Francis The Year in Heart Failure J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2344 - 2351. [Full Text] [PDF] |
||||
![]() |
A. Kazory, A. A. Ejaz, and E. A. Ross The UNLOAD Trial: A "Nephrologic" Standpoint J. Am. Coll. Cardiol., August 21, 2007; 50(8): 820 - 820. [Full Text] [PDF] |
||||
![]() |
M. R. Costanzo and on behalf of the UNLOAD Trial Investigators Reply J. Am. Coll. Cardiol., August 21, 2007; 50(8): 820 - 821. [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials JAMA, March 28, 2007; 297(12): 1332 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Yancy Climbing the Mountain of Acute Decompensated Heart Failure: The EVEREST Trials JAMA, March 28, 2007; 297(12): 1374 - 1376. [Full Text] [PDF] |
||||
![]() |
L. A. Allen and C. M. O'Connor Management of acute decompensated heart failure Can. Med. Assoc. J., March 13, 2007; 176(6): 797 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ultrafiltration for Acute Volume Overload in HF? Journal Watch Cardiology, February 28, 2007; 2007(228): 4 - 4. [Full Text] |
||||
![]() |
U. Elkayam, P. Hatamizadeh, and M. Janmohamed The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure J. Am. Coll. Cardiol., February 13, 2007; 49(6): 684 - 686. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |